These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28025665)

  • 1. MDS clinical diagnostic criteria for Parkinson's disease in China.
    Li J; Jin M; Wang L; Qin B; Wang K
    J Neurol; 2017 Mar; 264(3):476-481. PubMed ID: 28025665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the MDS clinical diagnostic criteria for Parkinson's disease.
    Postuma RB; Poewe W; Litvan I; Lewis S; Lang AE; Halliday G; Goetz CG; Chan P; Slow E; Seppi K; Schaffer E; Rios-Romenets S; Mi T; Maetzler C; Li Y; Heim B; Bledsoe IO; Berg D
    Mov Disord; 2018 Oct; 33(10):1601-1608. PubMed ID: 30145797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDS clinical diagnostic criteria for Parkinson's disease.
    Postuma RB; Berg D; Stern M; Poewe W; Olanow CW; Oertel W; Obeso J; Marek K; Litvan I; Lang AE; Halliday G; Goetz CG; Gasser T; Dubois B; Chan P; Bloem BR; Adler CH; Deuschl G
    Mov Disord; 2015 Oct; 30(12):1591-601. PubMed ID: 26474316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New Diagnostic Criteria for Parkinson's Disease: MDS-PD Criteria].
    Watanabe H; Hara K; Ito M; Katsuno M; Sobue G
    Brain Nerve; 2018 Feb; 70(2):139-146. PubMed ID: 29433115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases.
    Malek N; Lawton MA; Grosset KA; Bajaj N; Barker RA; Ben-Shlomo Y; Burn DJ; Foltynie T; Hardy J; Morris HR; Williams NM; Wood N; Grosset DG;
    Parkinsonism Relat Disord; 2017 Jul; 40():40-46. PubMed ID: 28431829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.
    Pilotto A; Heinzel S; Suenkel U; Lerche S; Brockmann K; Roeben B; Schaeffer E; Wurster I; Yilmaz R; Liepelt-Scarfone I; von Thaler AK; Metzger FG; Eschweiler GW; Postuma RB; Maetzler W; Berg D
    Mov Disord; 2017 Jul; 32(7):1025-1034. PubMed ID: 28509336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria.
    Martinez-Martin P; Falup-Pecurariu C; Rodriguez-Blazquez C; Serrano-Dueñas M; Carod Artal FJ; Rojo Abuin JM; Aarsland D
    Parkinsonism Relat Disord; 2011 Sep; 17(8):621-4. PubMed ID: 21684792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Barton B; Grabli D; Bernard B; Czernecki V; Goldman JG; Stebbins G; Dubois B; Goetz CG
    Mov Disord; 2012 Feb; 27(2):248-53. PubMed ID: 22162144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unified Parkinson's disease rating scale motor examination: are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable?
    Post B; Merkus MP; de Bie RM; de Haan RJ; Speelman JD
    Mov Disord; 2005 Dec; 20(12):1577-84. PubMed ID: 16116612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson's disease.
    Loftus AM; Bucks RS; Thomas M; Kane R; Timms C; Barker RA; Gasson N
    J Int Neuropsychol Soc; 2015 Feb; 21(2):137-45. PubMed ID: 25666735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?
    Virameteekul S; Revesz T; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
    Mov Disord; 2023 Apr; 38(4):558-566. PubMed ID: 36602274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorder society criteria for clinically established early Parkinson's disease.
    Berg D; Adler CH; Bloem BR; Chan P; Gasser T; Goetz CG; Halliday G; Lang AE; Lewis S; Li Y; Liepelt-Scarfone I; Litvan I; Marek K; Maetzler C; Mi T; Obeso J; Oertel W; Olanow CW; Poewe W; Rios-Romenets S; Schäffer E; Seppi K; Heim B; Slow E; Stern M; Bledsoe IO; Deuschl G; Postuma RB
    Mov Disord; 2018 Oct; 33(10):1643-1646. PubMed ID: 30145841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease and the quest for preclinical diagnosis: an interview with Professor Werner Poewe.
    Poewe W
    Neurodegener Dis Manag; 2017 Oct; 7(5):273-277. PubMed ID: 29043906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDS research criteria for prodromal Parkinson's disease.
    Berg D; Postuma RB; Adler CH; Bloem BR; Chan P; Dubois B; Gasser T; Goetz CG; Halliday G; Joseph L; Lang AE; Liepelt-Scarfone I; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M; Deuschl G
    Mov Disord; 2015 Oct; 30(12):1600-11. PubMed ID: 26474317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Criteria for Parkinson's Disease: From James Parkinson to the Concept of Prodromal Disease.
    Marsili L; Rizzo G; Colosimo C
    Front Neurol; 2018; 9():156. PubMed ID: 29628907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Prodromal Parkinson's Disease as Defined by MDS Research Criteria among Elderly Patients Undergoing Colonoscopy.
    Skorvanek M; Ladomirjakova Z; Han V; Lesko N; Feketeova E; Jarcuskova D; Repkova B; Spisak P; Urbancikova Z; Vargova A; Gombosova L; Zakuciova M; Veseliny E; Trebuna F; Mechirova E; Gdovinova Z
    J Parkinsons Dis; 2017; 7(3):481-489. PubMed ID: 28387681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
    Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
    Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.
    Gallagher DA; Goetz CG; Stebbins G; Lees AJ; Schrag A
    Mov Disord; 2012 Jan; 27(1):79-83. PubMed ID: 21915909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community.
    Mahlknecht P; Gasperi A; Willeit P; Kiechl S; Stockner H; Willeit J; Rungger G; Sawires M; Nocker M; Rastner V; Mair KJ; Hotter A; Poewe W; Seppi K
    Mov Disord; 2016 Sep; 31(9):1405-8. PubMed ID: 27273736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.